Dean T. Eurich - Publications

Affiliations: 
Public Health Sciences University of Alberta, Edmonton, Alberta, Canada 
Area:
Public Health, Pharmacy

107 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Alkabbani W, Shah BR, Zongo A, Eurich DT, Alsabbagh MW, Gamble JM. Post-initiation predictors of discontinuation of the sodium-glucose cotransporter-2 inhibitors: A comparative cohort study from the United Kingdom. Diabetes, Obesity & Metabolism. 25: 3490-3500. PMID 37563767 DOI: 10.1111/dom.15241  0.563
2022 Alkabbani W, Zongo A, Minhas-Sandhu JK, Eurich DT, Shah BR, Alsabbagh MW, Gamble JM. Five comparative cohorts to assess the risk of genital tract infections associated with sodium-glucose cotransporter-2 inhibitors initiation in type 2 diabetes mellitus. Diabetic Medicine : a Journal of the British Diabetic Association. e14858. PMID 35460294 DOI: 10.1111/dme.14858  0.62
2021 Alkabbani W, Zongo A, Minhas-Sandhu JK, Eurich DT, Shah BR, Alsabbagh MW, Gamble JM. Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score-matched Population-based Cohort Study. Canadian Journal of Diabetes. PMID 35513988 DOI: 10.1016/j.jcjd.2021.12.005  0.599
2021 Alkabbani W, Zongo A, Minhas-Sandhu JK, Eurich DT, Shah BR, Alsabbagh MW, Gamble JM. Renal effectiveness and safety of the sodium-glucose cotransporter-2 inhibitors: a population-based cohort study. Bmj Open Diabetes Research & Care. 9. PMID 34906925 DOI: 10.1136/bmjdrc-2021-002496  0.598
2021 Alkabbani W, Gamble JM, Eurich DT, Minhas-Sandhu JK, Shah BR, Alsabbagh MW, Zongo A. Risk of hospitalization and death associated with Sodium Glucose Cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs. Diabetes & Metabolism. 101305. PMID 34808344 DOI: 10.1016/j.diabet.2021.101305  0.604
2020 Voaklander B, Rowe S, Sanni O, Campbell S, Eurich D, Ospina MB. Prevalence of diabetes in pregnancy among Indigenous women in Australia, Canada, New Zealand, and the USA: a systematic review and meta-analysis. The Lancet. Global Health. 8: e681-e698. PMID 32353316 DOI: 10.1016/S2214-109X(20)30046-2  0.307
2020 Hall JJ, Eurich DT, Nagy D, Tjosvold L, Gamble JM. Thiazide Diuretic-Induced Change in Fasting Plasma Glucose: a Meta-analysis of Randomized Clinical Trials. Journal of General Internal Medicine. PMID 32157653 DOI: 10.1007/S11606-020-05731-3  0.624
2020 Wozniak LA, Johnson JA, Eurich DT. Working towards a better understanding of type 2 diabetes care organization with First Nations communities: a qualitative assessment. Archives of Public Health = Archives Belges De Sante Publique. 78: 7. PMID 32025300 DOI: 10.1186/S13690-020-0391-8  0.331
2019 Dubois TB, Simpson SH, Eurich DT. Time to Treatment Intensification in Newly Treated Adult Type 2 Diabetes Patients: Comparison of Canada and the United States. Canadian Journal of Diabetes. PMID 31831258 DOI: 10.1016/J.Jcjd.2019.09.002  0.329
2019 Zongo A, Simpson S, Johnson JA, Eurich DT. Change in Trajectories of Adherence to Lipid-Lowering Drugs Following Non-Fatal Acute Coronary Syndrome or Stroke. Journal of the American Heart Association. 8: e013857. PMID 31771443 DOI: 10.1161/Jaha.119.013857  0.325
2019 Zhao H, McClure NS, Johnson JA, Soprovich A, Al Sayah F, Eurich DT. A Longitudinal Study on the Association Between Diabetic Foot Disease and Health-Related Quality of Life in Adults With Type 2 Diabetes. Canadian Journal of Diabetes. PMID 31669187 DOI: 10.1016/J.Jcjd.2019.08.008  0.332
2019 Zongo A, Simpson S, Johnson JA, Eurich DT. Optimal threshold of adherence to lipid lowering drugs in predicting acute coronary syndrome, stroke, or mortality: A cohort study. Plos One. 14: e0223062. PMID 31553787 DOI: 10.1371/Journal.Pone.0223062  0.31
2019 Ye M, Robson PJ, Eurich DT, Vena JE, Xu JY, Johnson JA. Anthropometric changes and risk of diabetes: are there sex differences? A longitudinal study of Alberta's Tomorrow Project. Bmj Open. 9: e023829. PMID 31326923 DOI: 10.1136/Bmjopen-2018-023829  0.344
2019 Soprovich AL, Sharma V, Tjosvold L, Eurich DT, Johnson JA. Systematic review of community pharmacy-based and pharmacist-led foot care interventions for adults with type 2 diabetes. Canadian Pharmacists Journal : Cpj = Revue Des Pharmaciens Du Canada : Rpc. 152: 109-116. PMID 30886663 DOI: 10.1177/1715163519826166  0.329
2019 Soprovich A, Ingstrup M, Eurich DT. The frequency and availability of population-specific patient reported outcome measures and minimal clinically important differences among approved drugs in Canada. Health and Quality of Life Outcomes. 17: 4. PMID 30616654 DOI: 10.1186/S12955-018-1070-0  0.323
2019 Bhimji H, Eurich D, Mansell K, Mansell H. Potential and Realized Cost Savings with the Use of the Biosimilar Grastofil Vs Neupogen Blood. 134: 2126-2126. DOI: 10.1182/Blood-2019-122751  0.3
2019 Randall JR, Svenson L, Eurich D, Colquhoun A, Varughese M, Dewitt E, Bradburn K, Carriere C, Voklander D. 101 - Diabetes Prevalence and Incidence Among the Métis Canadian Journal of Diabetes. 43: S37. DOI: 10.1016/J.Jcjd.2019.07.110  0.324
2018 Law V, Featherstone T, Eurich DT, Simpson SH. Knowledge of a Diabetes Risk Score Does Not Alter Diabetes Screening Practice in a Seniors Population: A Randomized Controlled Trial. Journal of the American Medical Directors Association. PMID 30049541 DOI: 10.1016/J.Jamda.2018.06.001  0.333
2018 Zhao H, Johnson JA, Al Sayah F, Soprovich A, Eurich DT. The association of self-efficacy and hospitalization rates in people with type-2 diabetes: a prospective cohort study. Diabetes Research and Clinical Practice. PMID 29990566 DOI: 10.1016/J.Diabres.2018.07.011  0.33
2018 Eskin M, Eurich DT, Simpson SH. Impact of Drug Exposure Definitions on Observed Associations in Pharmacoepidemiology Research. Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharamcologie Clinique. 25: e39-e52. PMID 29949683 DOI: 10.22374/1710-6222.25.1.4  0.33
2018 Weir DL, Abrahamowicz M, Beauchamp ME, Eurich DT. Acute vs Cumulative Benefits of Metformin use in Patients with Type 2 Diabetes and Heart Failure. Diabetes, Obesity & Metabolism. PMID 29934961 DOI: 10.1111/Dom.13448  0.355
2018 Lipscombe L, Booth G, Butalia S, Dasgupta K, Eurich DT, Goldenberg R, Khan N, MacCallum L, Shah BR, Simpson S. Erratum to "Pharmacologic Glycemic Management of Type 2 Diabetes in Adults": Canadian Journal of Diabetes 2018;42(S1):S88-S103. Canadian Journal of Diabetes. 42: 336. PMID 29857811 DOI: 10.1016/J.Jcjd.2018.04.005  0.31
2018 Lipscombe L, Booth G, Butalia S, Dasgupta K, Eurich DT, Goldenberg R, Khan N, MacCallum L, Shah BR, Simpson S. Pharmacologic Glycemic Management of Type 2 Diabetes in Adults. Canadian Journal of Diabetes. 42: S88-S103. PMID 29650116 DOI: 10.1016/J.Jcjd.2017.10.034  0.305
2018 Weir D, Samanani S, Niruban SJ, Jess E, Gilani F, Eurich D. A Population-Based Examination of Benzodiazepine Receptor Agonist & Z-drug Dispensations in the Alberta Population: Prevalence of Use and Indicators of Potentially Inappropriate Use and Prescribing International Journal of Population Data Science. 3. DOI: 10.23889/Ijpds.V3I4.828  0.307
2018 Ye M, Vena J, Xu J, Robson P, Eurich D, Johnson J. Cross-validation of Drug Use Records in Two Pharmaceutical Databases: A Population-based Study of Alberta’s Tomorrow Project Cohort International Journal of Population Data Science. 3. DOI: 10.23889/Ijpds.V3I4.663  0.343
2017 Ye M, Robson PJ, Eurich DT, Vena JE, Xu JY, Johnson JA. Systemic Use of Antibiotics and Risk of Diabetes in Adults: A Nested Case-control Study of Alberta's Tomorrow Project. Diabetes, Obesity & Metabolism. PMID 29152889 DOI: 10.1111/Dom.13163  0.353
2017 Ye M, Robson PJ, Eurich DT, Vena JE, Xu JY, Johnson JA. Changes in body mass index and incidence of diabetes: A longitudinal study of Alberta's Tomorrow Project Cohort. Preventive Medicine. PMID 29117506 DOI: 10.1016/J.Ypmed.2017.10.036  0.349
2017 Marrie TJ, Tyrrell GJ, Majumdar SR, Eurich DT. Risk factors for pneumococcal endocarditis. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. PMID 29067623 DOI: 10.1007/S10096-017-3128-Z  0.363
2017 Soprovich A, El Kurdi S, Eurich DT. An analysis of redactions in Canada's Common Drug Review Clinical Review Reports and how they relate to the patients' voice. Bmj Open. 7: e015497. PMID 28893743 DOI: 10.1136/Bmjopen-2016-015497  0.329
2017 Schultz M, Keeling SO, Katz SJ, Maksymowych WP, Eurich DT, Hall JJ. Clinical effectiveness and safety of leflunomide in inflammatory arthritis: a report from the RAPPORT database with supporting patient survey. Clinical Rheumatology. PMID 28550389 DOI: 10.1007/S10067-017-3687-5  0.308
2017 Marrie TJ, Tyrrell GJ, Majumdar SR, Eurich DT. Invasive Pneumococcal Disease: Still Lots to Learn and a Need for Standardized Data Collection Instruments. Canadian Respiratory Journal. 2017: 2397429. PMID 28424565 DOI: 10.1155/2017/2397429  0.327
2017 McAlister FA, Youngson E, Eurich DT. Treatment Deintensification Is Uncommon in Adults With Type 2 Diabetes Mellitus: A Retrospective Cohort Study. Circulation. Cardiovascular Quality and Outcomes. 10. PMID 28416531 DOI: 10.1161/Circoutcomes.116.003514  0.358
2017 Featherstone T, Eurich DT, Simpson SH. Limited Effectiveness of Diabetes Risk Assessment Tools in Seniors' Facility Residents. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 20: 329-335. PMID 28292477 DOI: 10.1016/J.Jval.2016.09.2403  0.338
2017 Eurich DT, Marrie TJ, Minhas-Sandhu JK, Majumdar SR. Risk of heart failure after community acquired pneumonia: prospective controlled study with 10 years of follow-up. Bmj (Clinical Research Ed.). 356: j413. PMID 28193610 DOI: 10.1136/Bmj.J413  0.316
2017 Eurich DT, Majumdar SR, Wozniak LA, Soprovich A, Meneen K, Johnson JA, Samanani S. Addressing the gaps in diabetes care in first nations communities with the reorganizing the approach to diabetes through the application of registries (RADAR): the project protocol. Bmc Health Services Research. 17: 117. PMID 28166804 DOI: 10.1186/S12913-017-2049-Y  0.337
2017 Meneen KJ, Van Weelden DM, Samanani S, Johnson JA, Wozniak LA, Majumdar SR, Eurich DT. RADAR: Perceived Barriers and Facilitators to Diabetes Management in First Nations Communities Canadian Journal of Diabetes. 41: S82. DOI: 10.1016/J.Jcjd.2017.08.257  0.302
2017 Eurich DT, Majumdar SR, Wozniak LA, Soprovich A, Meneen K, Johnson JA, Samanani S. Reorganizing the Approach to Diabetes through the Application of Registries (RADAR) in First Nations Communities Canadian Journal of Diabetes. 41: S81-S82. DOI: 10.1016/J.Jcjd.2017.08.236  0.312
2016 Booth G, Lipscombe L, Butalia S, Dasgupta K, Eurich D, Goldenberg R, Khan N, MacCallum L, Shah B, Simpson S, Houlden RL. Pharmacologic Management of Type 2 Diabetes: 2016 Interim Update Canadian Journal of Diabetes. 40: 484-486. PMID 27912867 DOI: 10.1016/J.Jcjd.2016.09.003  0.322
2016 Johnson ST, Eurich DT, Lytvyak E, Mladenovic A, Taylor LM, Johnson JA, Vallance JK. Walking and type 2 diabetes risk using CANRISK scores among older adults. Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme. 1-6. PMID 27903089 DOI: 10.1139/Apnm-2016-0267  0.349
2016 Beatty JA, Majumdar SR, Tyrrell GJ, Marrie TJ, Eurich DT. Prognostic factors associated with mortality and major in-hospital complications in patients with bacteremic pneumococcal pneumonia: Population-based study. Medicine. 95: e5179. PMID 27861340 DOI: 10.1097/Md.0000000000005179  0.335
2016 McAlister FA, Youngson E, Eurich DT. Treated glycosylated hemoglobin levels in individuals with diabetes mellitus vary little by health status: A retrospective cohort study. Medicine. 95: e3894. PMID 27310986 DOI: 10.1097/Md.0000000000003894  0.382
2016 Simpson SH, Lin M, Eurich DT. Medication Adherence Affects Risk of New Diabetes Complications: A Cohort Study. The Annals of Pharmacotherapy. PMID 27307411 DOI: 10.1177/1060028016653609  0.345
2016 Abdelmoneim AS, Eurich DT, Senthilselvan A, Qiu W, Simpson SH. Dose-response relationship between sulfonylureas and major adverse cardiovascular events in elderly patients with type 2 diabetes. Pharmacoepidemiology and Drug Safety. PMID 27102581 DOI: 10.1002/Pds.4014  0.305
2016 Majumdar SR, Josse RG, Lin M, Eurich DT. Does Sitagliptin Affect the Rate of Osteoporotic Fractures in Type-2 Diabetes? Population-Based Cohort Study. The Journal of Clinical Endocrinology and Metabolism. jc20154180. PMID 26930183 DOI: 10.1210/Jc.2015-4180  0.325
2016 Weir DL, McAlister FA, Majumdar SR, Eurich DT. The Interplay Between Continuity of Care, Multimorbidity, and Adverse Events in Patients With Diabetes. Medical Care. PMID 26807539 DOI: 10.1097/Mlr.0000000000000493  0.352
2015 Milliken D, Venkatesh J, Yu R, Su Z, Thompson M, Eurich D. Comparison of drug coverage in Canada before and after the establishment of the pan-Canadian Pharmaceutical Alliance. Bmj Open. 5: e008100. PMID 26341583 DOI: 10.1136/Bmjopen-2015-008100  0.31
2015 Padwal R, Lin M, Eurich DT. The Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes. Journal of Clinical Hypertension (Greenwich, Conn.). PMID 26289255 DOI: 10.1111/Jch.12647  0.363
2015 Abdelmoneim AS, Eurich DT, Light PE, Senior PA, Seubert JM, Makowsky MJ, Simpson SH. Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer. Diabetes, Obesity & Metabolism. 17: 523-32. PMID 25711240 DOI: 10.1111/Dom.12456  0.344
2015 Weir DL, Majumdar SR, McAlister FA, Marrie TJ, Eurich DT. The impact of multimorbidity on short-term events in patients with community-acquired pneumonia: prospective cohort study. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 21: 264.e7-264.e13. PMID 25658532 DOI: 10.1016/J.Cmi.2014.11.002  0.35
2015 Gamble JM, Johnson JA, McAlister FA, Majumdar SR, Simpson SH, Eurich DT. Limited impact of drug exposure misclassification from non-benefit thiazolidinedione drug use on mortality and hospitalizations from Saskatchewan, Canada: a cohort study. Clinical Therapeutics. 37: 629-42. PMID 25596665 DOI: 10.1016/J.Clinthera.2014.12.014  0.64
2015 Dang TT, Majumdar SR, Marrie TJ, Eurich DT. Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients. Drugs & Aging. 32: 13-9. PMID 25491559 DOI: 10.1007/S40266-014-0229-6  0.339
2014 Weir DL, McAlister FA, Senthilselvan A, Minhas-Sandhu JK, Eurich DT. Sitagliptin use in patients with diabetes and heart failure: a population-based retrospective cohort study. Jacc. Heart Failure. 2: 573-82. PMID 24998080 DOI: 10.1016/J.Jchf.2014.04.005  0.34
2014 Dang TT, Eurich DT, Weir DL, Marrie TJ, Majumdar SR. Rates and risk factors for recurrent pneumonia in patients hospitalized with community-acquired pneumonia: population-based prospective cohort study with 5 years of follow-up. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 74-80. PMID 24729503 DOI: 10.1093/Cid/Ciu247  0.344
2014 Gamble JM, Hall JJ, Marrie TJ, Sadowski CA, Majumdar SR, Eurich DT. Medication transitions and polypharmacy in older adults following acute care. Therapeutics and Clinical Risk Management. 10: 189-96. PMID 24672243 DOI: 10.2147/Tcrm.S58707  0.623
2014 Alsabbagh MH, Lemstra M, Eurich D, Lix LM, Wilson TW, Watson E, Blackburn DF. Socioeconomic status and nonadherence to antihypertensive drugs: a systematic review and meta-analysis. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: 288-96. PMID 24636389 DOI: 10.1016/J.Jval.2013.11.011  0.301
2014 Weir DL, Johnson ST, Mundt C, Bray D, Taylor L, Eurich DT, Johnson JA. A primary care based healthy-eating and active living education session for weight reduction in the pre-diabetic population. Primary Care Diabetes. 8: 301-7. PMID 24582002 DOI: 10.1016/J.Pcd.2014.01.013  0.311
2014 Padwal R, Lin M, Etminan M, Eurich DT. Comparative effectiveness of olmesartan and other angiotensin receptor blockers in diabetes mellitus: retrospective cohort study. Hypertension. 63: 977-83. PMID 24535009 DOI: 10.1161/Hypertensionaha.113.02855  0.378
2014 Asche CV, Hippler SE, Eurich DT. Review of models used in economic analyses of new oral treatments for type 2 diabetes mellitus. Pharmacoeconomics. 32: 15-27. PMID 24357160 DOI: 10.1016/J.Jval.2014.03.1121  0.319
2014 Gamble JM, Majumdar SR, Johnson JA, McAlister FA, Simpson SH, Eurich DT. Changes in thiazolidinedione use and outcomes following removal of a prior-authorization policy: controlled time-series analysis. Medical Care. 52: 47-55. PMID 24309670 DOI: 10.1097/Mlr.0000000000000006  0.598
2014 Sligl WI, Asadi L, Eurich DT, Tjosvold L, Marrie TJ, Majumdar SR. Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis. Critical Care Medicine. 42: 420-32. PMID 24158175 DOI: 10.1097/Ccm.0B013E3182A66B9B  0.316
2014 Abdelmoneim AS, Eurich DT, Gamble JM, Johnson JA, Seubert JM, Qiu W, Simpson SH. Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: a nested case-control study. Diabetes, Obesity & Metabolism. 16: 22-9. PMID 23802997 DOI: 10.1111/Dom.12173  0.374
2013 Abdelmoneim AS, Eurich DT, Gamble JM, Simpson SH. Use patterns of antidiabetic regimens by patients with type 2 diabetes. Canadian Journal of Diabetes. 37: 394-400. PMID 24321720 DOI: 10.1016/J.Jcjd.2013.04.008  0.645
2013 Eurich DT, Simpson S, Senthilselvan A, Asche CV, Sandhu-Minhas JK, McAlister FA. Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study. Bmj (Clinical Research Ed.). 346: f2267. PMID 23618722 DOI: 10.1136/Bmj.F2267  0.384
2013 Eurich DT, Weir DL, Majumdar SR, Tsuyuki RT, Johnson JA, Tjosvold L, Vanderloo SE, McAlister FA. Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients. Circulation. Heart Failure. 6: 395-402. PMID 23508758 DOI: 10.1161/Circheartfailure.112.000162  0.338
2013 Gamble JM, Johnson JA, Majumdar SR, McAlister FA, Simpson SH, Eurich DT. Evaluating the introduction of a computerized prior-authorization system on the completeness of drug exposure data. Pharmacoepidemiology and Drug Safety. 22: 551-5. PMID 23475736 DOI: 10.1002/Pds.3427  0.611
2013 Asadi L, Eurich DT, Gamble JM, Minhas-Sandhu JK, Marrie TJ, Majumdar SR. Impact of guideline-concordant antibiotics and macrolide/β-lactam combinations in 3203 patients hospitalized with pneumonia: prospective cohort study. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 19: 257-64. PMID 22404691 DOI: 10.1111/J.1469-0691.2012.03783.X  0.326
2012 Gamble JM, Hoang H, Eurich DT, Jindal KK, Senior PA. Patient-level evaluation of community-based, multifactorial intervention to prevent diabetic nephropathy in northern alberta, Canada. Journal of Primary Care & Community Health. 3: 111-9. PMID 23803454 DOI: 10.1177/2150131911417718  0.644
2012 MacIntyre EJ, Majumdar SR, Gamble JM, Minhas-Sandhu JK, Marrie TJ, Eurich DT. Stress hyperglycemia and newly diagnosed diabetes in 2124 patients hospitalized with pneumonia. The American Journal of Medicine. 125: 1036.e17-23. PMID 22863217 DOI: 10.1016/J.Amjmed.2012.01.026  0.648
2012 Eurich DT, Majumdar SR, Marrie TJ. Population-based cohort study of outpatients with pneumonia: rationale, design and baseline characteristics. Bmc Infectious Diseases. 12: 135. PMID 22709357 DOI: 10.1186/1471-2334-12-135  0.351
2012 Gamble JM, McAlister FA, Johnson JA, Eurich DT. Restrictive drug coverage policies can induce substantial drug exposure misclassification in pharmacoepidemiologic studies. Clinical Therapeutics. 34: 1379-1386.e3. PMID 22554975 DOI: 10.1016/J.Clinthera.2012.04.009  0.622
2012 Asadi L, Sligl WI, Eurich DT, Colmers IN, Tjosvold L, Marrie TJ, Majumdar SR. Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 55: 371-80. PMID 22511553 DOI: 10.1093/Cid/Cis414  0.333
2012 Gamble JM, McAlister FA, Johnson JA, Eurich DT. Quantifying the impact of drug exposure misclassification due to restrictive drug coverage in administrative databases: a simulation cohort study. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 15: 191-7. PMID 22264988 DOI: 10.1016/J.Jval.2011.08.005  0.626
2012 Asadi L, Eurich DT, Gamble JM, Minhas-Sandhu JK, Marrie TJ, Majumdar SR. Guideline adherence and macrolides reduced mortality in outpatients with pneumonia. Respiratory Medicine. 106: 451-8. PMID 22182341 DOI: 10.1016/J.Rmed.2011.11.017  0.614
2012 Eurich DT, Majumdar SR. Statins and sepsis - scientifically interesting but clinically inconsequential. Journal of General Internal Medicine. 27: 268-9. PMID 22135140 DOI: 10.1007/S11606-011-1939-7  0.371
2012 Abdelmoneim AS, Eurich DT, Gamble J, Johnson JA, Seubert J, Qiu W, Simpson SH. Glyburide is Associated with a Higher Risk of Acute Coronary Events Compared to Gliclazide: A Nested Case-control Study Canadian Journal of Diabetes. 36: S21-S22. DOI: 10.1016/J.Jcjd.2012.07.088  0.596
2011 Gamble JM, Weir DL, Johnson JA, Eurich DT. Analysis of drug coverage before and after the implementation of Canada's Common Drug Review. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 183: E1259-66. PMID 22025648 DOI: 10.1503/Cmaj.110670  0.621
2011 Evans CD, Watson E, Eurich DT, Taylor JG, Yakiwchuk EM, Shevchuk YM, Remillard A, Blackburn D. Diabetes and cardiovascular disease interventions by community pharmacists: a systematic review. The Annals of Pharmacotherapy. 45: 615-28. PMID 21558487 DOI: 10.1345/Aph.1P615  0.339
2011 Eurich DT, McAlister FA. Wrongfully accused: metformin use in heart failure. Expert Review of Cardiovascular Therapy. 9: 147-50. PMID 21453211 DOI: 10.1586/Erc.10.186  0.354
2011 Gamble JM, Eurich DT, Ezekowitz JA, Kaul P, Quan H, McAlister FA. Patterns of care and outcomes differ for urban versus rural patients with newly diagnosed heart failure, even in a universal healthcare system. Circulation. Heart Failure. 4: 317-23. PMID 21430285 DOI: 10.1161/Circheartfailure.110.959262  0.608
2011 Majumdar SR, Eurich DT, Gamble JM, Senthilselvan A, Marrie TJ. Oxygen saturations less than 92% are associated with major adverse events in outpatients with pneumonia: a population-based cohort study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 325-31. PMID 21217179 DOI: 10.1093/Cid/Ciq076  0.62
2011 Sligl WI, Eurich DT, Marrie TJ, Majumdar SR. Only severely limited, premorbid functional status is associated with short- and long-term mortality in patients with pneumonia who are critically ill: a prospective observational study. Chest. 139: 88-94. PMID 20688920 DOI: 10.1378/Chest.10-1054  0.303
2010 Gamble JM, Eurich DT, Johnson JA. A comparison of drug coverage in alberta before and after the introduction of the national common drug review process. Healthcare Policy = Politiques De Santé. 6: e117-44. PMID 22043227 DOI: 10.12927/Hcpol.2010.22037  0.619
2010 Evans CD, Eurich DT, Taylor JG, Blackburn DF. The Collaborative Cardiovascular Risk Reduction in Primary Care (CCARP) study. Pharmacotherapy. 30: 766-75. PMID 20653352 DOI: 10.1592/Phco.30.8.766  0.314
2010 Gamble JM, Eurich DT, Marrie TJ, Majumdar SR. Admission hypoglycemia and increased mortality in patients hospitalized with pneumonia. The American Journal of Medicine. 123: 556.e11-6. PMID 20569764 DOI: 10.1016/J.Amjmed.2009.11.021  0.63
2010 MacDonald MR, Eurich DT, Majumdar SR, Lewsey JD, Bhagra S, Jhund PS, Petrie MC, McMurray JJ, Petrie JR, McAlister FA. Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database. Diabetes Care. 33: 1213-8. PMID 20299488 DOI: 10.2337/Dc09-2227  0.338
2010 Eurich DT, Sadowski CA, Simpson SH, Marrie TJ, Majumdar SR. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs. The American Journal of Medicine. 123: 47-53. PMID 20102991 DOI: 10.1016/J.Amjmed.2009.05.032  0.338
2010 Eurich DT, Gamble JM, Marrie TJ, Majumdar SR. Dysglycaemia and 90 day and 1 year risks of death or readmission in patients hospitalised for community-acquired pneumonia. Diabetologia. 53: 497-503. PMID 19936702 DOI: 10.1007/S00125-009-1598-Y  0.327
2010 Gamble JM, Simpson SH, Eurich DT, Majumdar SR, Johnson JA. Insulin use and increased risk of mortality in type 2 diabetes: a cohort study. Diabetes, Obesity & Metabolism. 12: 47-53. PMID 19788429 DOI: 10.1111/J.1463-1326.2009.01125.X  0.366
2010 Gamble J, Eurich D, Johnson J. A Comparison of Drug Coverage in Alberta Before and After the Introduction of the National Common Drug Review Process Healthcare Policy | Politiques De Santé. 6: e117-e144. DOI: 10.12927/hcpol.2010.22037  0.583
2009 Leung AA, Eurich DT, Lamb DA, Majumdar SR, Johnson JA, Blackburn DF, McAlister FA. Risk of heart failure in patients with recent-onset type 2 diabetes: population-based cohort study. Journal of Cardiac Failure. 15: 152-7. PMID 19254675 DOI: 10.1016/J.Cardfail.2008.10.004  0.354
2009 Eurich DT, Tsuyuki RT, Majumdar SR, McAlister FA, Lewanczuk R, Shibata MC, Johnson JA. Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality. Trials. 10: 12. PMID 19203392 DOI: 10.1186/1745-6215-10-12  0.314
2009 Gamble J, Eurich D, Marrie T, Majumdar S. Admission hypoglycaemia portends a substantially increased risk of mortality in patients with community- acquired pneumonia: population-based cohort study Canadian Journal of Diabetes. 33: 185. DOI: 10.1016/S1499-2671(09)33015-4  0.64
2008 Johnstone J, Eurich DT, Majumdar SR, Jin Y, Marrie TJ. Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study. Medicine. 87: 329-34. PMID 19011504 DOI: 10.1097/Md.0B013E318190F444  0.342
2008 Eurich DT, Gamble JM, Simpson SH, Johnson JA. The darkening cloud of diabetes: do trends in cardiovascular risk management provide a silver lining? Diabetes Care. 31: 2136-42. PMID 18840767 DOI: 10.2337/Dc08-1248  0.667
2008 McAlister FA, Eurich DT, Majumdar SR, Johnson JA. The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy. European Journal of Heart Failure. 10: 703-8. PMID 18571471 DOI: 10.1016/J.Ejheart.2008.05.013  0.348
2008 Eurich DT, Majumdar SR. Review: thiazolidinediones increase congestive heart failure but not cardiovascular deaths in prediabetes or type 2 diabetes. Acp Journal Club. 148: 39. PMID 18311869 DOI: 10.7326/Acpjc-2008-148-2-039  0.326
2007 Eurich DT, McAlister FA, Blackburn DF, Majumdar SR, Tsuyuki RT, Varney J, Johnson JA. Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. Bmj (Clinical Research Ed.). 335: 497. PMID 17761999 DOI: 10.1136/Bmj.39314.620174.80  0.336
2006 Rucker D, Johnson JA, Lee TK, Eurich DT, Lewanczuk RZ, Simpson SH, Toth EL, Majumdar SR. The natural history of LDL control in type 2 diabetes: a prospective study of adherence to lipid guidelines. Diabetes Care. 29: 2506-8. PMID 17065693 DOI: 10.2337/Dc06-1205  0.346
2006 Majumdar SR, McAlister FA, Eurich DT, Padwal RS, Marrie TJ. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. Bmj (Clinical Research Ed.). 333: 999. PMID 17060337 DOI: 10.1136/Bmj.38992.565972.7C  0.348
2006 Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, Johnson JA. A meta-analysis of the association between adherence to drug therapy and mortality. Bmj (Clinical Research Ed.). 333: 15. PMID 16790458 DOI: 10.1136/Bmj.38875.675486.55  0.316
2006 Johnson JA, Simpson SH, Eurich DT, Majumdar SR. Comment on: Evans JM, Ogston SA, Emslie-Smith A, Morris A (2006) risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930-936. Diabetologia. 49: 2805-6. PMID 16788800 DOI: 10.1007/S00125-006-0323-3  0.361
2006 Simpson SH, Majumdar SR, Tsuyuki RT, Eurich DT, Johnson JA. Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 174: 169-74. PMID 16415461 DOI: 10.1503/Cmaj.050748  0.401
2005 Hughes CA, Cashin RP, Eurich DT, Houston S. Risk factors for new-onset diabetes mellitus in patients receiving protease inhibitor therapy. The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie MéDicale / Ammi Canada. 16: 230-2. PMID 18159550 DOI: 10.1155/2005/971971  0.346
2005 Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Johnson JA. Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care. 28: 2345-51. PMID 16186261 DOI: 10.2337/Diacare.28.10.2345  0.339
2005 Eurich DT, Simpson SH, Majumdar SR, Johnson JA. Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus. Pharmacotherapy. 25: 810-6. PMID 15927899 DOI: 10.1592/Phco.2005.25.6.810  0.333
2005 Johnson JA, Eurich DT, Toth EL, Lewanczuk RZ, Lee TK, Majumdar SR. Generalizability and persistence of a multifaceted intervention for improving quality of care for rural patients with type 2 diabetes. Diabetes Care. 28: 783-8. PMID 15793173 DOI: 10.2337/Diacare.28.4.783  0.342
2004 Eurich DT, Majumdar SR, Tsuyuki RT, Johnson JA. Reduced mortality associated with the use of ACE inhibitors in patients with type 2 diabetes. Diabetes Care. 27: 1330-4. PMID 15161784 DOI: 10.2337/Diacare.27.6.1330  0.372
Show low-probability matches.